carboplatin,nivolumab,cisplatin,pemetrexed,ipilimumab,Pembrolizumab
bms,merck
['check,mate,227', 'thoracic', 'mesothelioma', 'lioi', 'checkmate 743']
io+chemo work in all thoracic malignancies including pleural mesothelioma: ind227 trial. results mirror checkmate 743. today the dilemma in 1st l: io+io vs io+ct?
we need predictive mrk for choosing 1st l or decide based on histology subtype:io+io non-epithelioid? #asco2023 
Medical Oncologist - Thoracic tumors. Personalized treatment approches @EORTC